Senior Director, Global Regulatory Strategy
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions.
Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work® in 2026.
Description of Role
As the Senior Director, Global Regulatory Strategy you will report to the VP, Regulatory and Medical Writing and serve as a key member within our regulatory team, providing strategic and operational regulatory leadership across global development programs. As the Regulatory Lead for assigned assets, you will develop and execute global regulatory strategies spanning nonclinical, clinical, and registration activities, including leading NDA planning, preparation, and submiss
